Scorpion Therapeutics

dynamic arrows moving up

Biotech

US biotechs must adapt as global competition rises: Antares CEO

Antares CEO Adam Friedman said he’s had to shift his strategy amid high costs, regulatory uncertainty and the rise of ex-U.S. competition.

Gabrielle Masson Jun 17, 2025 8:15am

Alps parachute rainbow mountains

Sanofi vaccine vet vaults to GSK—Chutes & Ladders

Jun 13, 2025 8:30am

Antares and Rho Ophiuchi cloud complex in the Sagittarius constellation

Scorpion spinout Antares raises $177M for preclinical portfolio

Jun 10, 2025 10:07am

Scorpion

Lilly inks $2.5B Scorpion buyout in twist to breast cancer tale

Jan 13, 2025 9:55am

Fierce 15

Where are they now? Catching up with past Fierce 15 honorees

Oct 18, 2024 9:39am

Scorpion

Scorpion snaps up $150M series C to broaden clinical plans

Jul 16, 2024 9:40am